Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Inclusion Criteria: * Healthy Subjects 18 years of age who signed the informed consent Exclusion Criteria: * Receipt of another investigational agent within 4 weeks * Receipt of influenza vaccination for current season 2006/2007. * any acute disease or infection, history of neurological symptoms or signs, known or suspected impairment of immune function, any serious disease, bleeding diathesis * fever (defined as axillary temperature ³38.0°C) within 3 days (prior to Visit 1) * Pregnant or breastfeeding or females of childbearing potential who refuse to use an acceptable method of birth control * Surgery planned during the study period * Hypersensitivity to eggs, chicken protein, chicken feathers, influenza viral protein, neomycin or polymyxin or any other component of the study vaccine * Receipt of another vaccine within 3 weeks prior to Visit 1 or planned vaccination within 3 weeks following the last study vaccination * History of (or current) drug or alcohol abuse * Any condition, which, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.